ECSP993165A - PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION - Google Patents

PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION

Info

Publication number
ECSP993165A
ECSP993165A ECSP993165A ECSP993165A EC SP993165 A ECSP993165 A EC SP993165A EC SP993165 A ECSP993165 A EC SP993165A EC SP993165 A ECSP993165 A EC SP993165A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical formulations
controlled liberation
liberation
controlled
formulations
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Ross James Macrae
Elizabeth King
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993165 priority Critical patent/ECSP993165A/en
Publication of ECSP993165A publication Critical patent/ECSP993165A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona formulaciones farmacéuticas de liberación controlada para administración oral quwe contienen un inhibidor GMPc PDE-5 . Las formulaciones son útiles, entre otros, en el tratamiento o prevención de la disfunción sexual.The invention provides controlled release pharmaceutical formulations for oral administration that contain a cGMP PDE-5 inhibitor. The formulations are useful, among others, in the treatment or prevention of sexual dysfunction.

ECSP993165 1999-10-04 1999-10-04 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION ECSP993165A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993165 ECSP993165A (en) 1999-10-04 1999-10-04 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993165 ECSP993165A (en) 1999-10-04 1999-10-04 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION

Publications (1)

Publication Number Publication Date
ECSP993165A true ECSP993165A (en) 1999-11-29

Family

ID=42044153

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993165 ECSP993165A (en) 1999-10-04 1999-10-04 PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION

Country Status (1)

Country Link
EC (1) ECSP993165A (en)

Similar Documents

Publication Publication Date Title
CO5160262A1 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED LIBERATION
NO993520L (en) Dosage forms and methods for better erectile dysfunction
PA8476301A1 (en) INTRANASAL FORMULATIONS TO TREAT SEXUAL DISORDERS
HUP0101543A3 (en) Pharmaceutical compositions for treating femal sexual dysfunction
AR037109A1 (en) USE OF FLIBANSERINE
ES2191152T3 (en) COMBINED THERAPY FOR THE TREATMENT OF PSYCHOSIS.
ES2183937T3 (en) INHIBITORS OF THE CELL ADHESION.
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
HN2004000319A (en) "{1,8} NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA"
PT1073658E (en) OGMP INHIBITORS PYRAZOLOPYRYIDINONE PDES FOR THE TREATMENT OF SEXUAL DYSFUNCTION
MX9703868A (en) cGMP-PDE INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION.
ATE302616T1 (en) MEDICINAL COMPOSITIONS FOR ORAL APPLICATION WITH CONTROLLED RELEASE OF ACTIVE INGREDIENTS
MXPA04009352A (en) COMBINATION THERAPY FOR THE TREATMENT OF PARKINSONaCOES DISEASE WITH CYCLOOXYGENASE-2 (COX 2) INHIBITOR(S).
GT199800177A (en) EFFECTIVE COMBINATION FOR THE TREATMENT OF IMPOTENCE.
HN2000000268A (en) COMPOUNDS, COMPOSITIONS AND METHODS TO STIMULATE THE GROWTH AND ELONGATION OF NEURONS
AR052774A1 (en) IMMUNOTHERAPY FOR AUTOIMMUNE DISORDERS
UY26889A1 (en) PHARMACEUTICAL COMPOUNDS
ECSP055701A (en) NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME
GT199900183A (en) GMP DE5 INHIBITING PIRAZOLOPIRIMIDONAS FOR THE TREATMENT OF SEXUAL DYSFUNCTION.
HN2003000063A (en) NICOTINAMIDE DERIVATIVES AND A COMBINATION TIOTROPIO SALT FOR THE TREATMENT OF DISEASES.
TW200612919A (en) Lonidamine analogues and their use in male contraception and cancer treatment
SV2002000235A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE VALDECOXIB
TW200509998A (en) Controlled release of highly soluble agents
CO5540294A2 (en) A COMBINATION OF A RAPAMYCIN DERIVATIVE AND A SELECTED RENTING AGENT OF CYCLPHOSPHAMIDE AND CARMUSTINE AND COMPOSITIONS CONTAINING THEM
AR046402A1 (en) COMBINATION OF ACTIVE PRINCIPLE THAT INCLUDES A 2,5-DIHYDROBENCENOSULPHONIC COMPOUND AND A POTASSIUM CHANNEL MODULATOR